BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 30072151)

  • 1. Antihypertensive drugs and relevant cardiovascular pharmacotherapies and the risk of incident dementia in patients with atrial fibrillation.
    Wändell P; Carlsson AC; Sundquist J; Sundquist K
    Int J Cardiol; 2018 Dec; 272():149-154. PubMed ID: 30072151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of prescribed antihypertensives and other cardiovascular drugs on mortality in patients with atrial fibrillation and hypertension: a cohort study from Sweden.
    Carlsson AC; Wändell P; Sundquist K; Johansson SE; Sundquist J
    Hypertens Res; 2014 Jun; 37(6):553-9. PubMed ID: 24599014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cardiovascular pharmacotherapies on incident dementia in patients with atrial fibrillation: A cohort study of all patients above 45 years diagnosed with AF in hospitals in Sweden.
    Wändell P; Carlsson AC; Li X; Sundquist J; Sundquist K
    Int J Cardiol; 2019 Dec; 297():55-60. PubMed ID: 31619361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Relevant Co-Morbidities and Dementia With Atrial Fibrillation-A National Study.
    Wändell P; Carlsson AC; Li X; Sundquist J; Sundquist K
    Arch Med Res; 2019 Feb; 50(2):29-35. PubMed ID: 31349951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between relevant cardiovascular pharmacotherapies and incident heart failure in patients with atrial fibrillation: a cohort study in primary care.
    Wändell P; Carlsson AC; Holzmann MJ; Ärnlöv J; Sundquist J; Sundquist K
    J Hypertens; 2018 Sep; 36(9):1929-1935. PubMed ID: 29870433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy and mortality in atrial fibrillation--a cohort of men and women 75 years or older in Sweden.
    Wändell PE; Carlsson AC; Sundquist J; Johansson SE; Bottai M; Sundquist K
    Age Ageing; 2015 Mar; 44(2):232-8. PubMed ID: 25324331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of cardiovascular drugs and risk of incident heart failure in patients with atrial fibrillation.
    Wändell P; Carlsson AC; Li X; Holzmann MJ; Sundquist J; Sundquist K
    J Clin Hypertens (Greenwich); 2020 Aug; 22(8):1396-1405. PubMed ID: 32667702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of RAAS Blockers on Atrial Fibrillation Prophylaxis: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Chaugai S; Meng WY; Ali Sepehry A
    J Cardiovasc Pharmacol Ther; 2016 Jul; 21(4):388-404. PubMed ID: 26817632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renin-angiotensin-aldosterone system inhibitors and mortality risk in elderly patients with atrial fibrillation. Insights from the nationwide START registry.
    Menichelli D; Poli D; Antonucci E; Palareti G; Pignatelli P; Pastori D;
    Eur J Intern Med; 2024 Jan; 119():84-92. PubMed ID: 37648584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).
    Haywood LJ; Ford CE; Crow RS; Davis BR; Massie BM; Einhorn PT; Williard A;
    J Am Coll Cardiol; 2009 Nov; 54(22):2023-31. PubMed ID: 19926008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of antihypertensive drugs and drug combinations on the incidence of new-onset type-2 diabetes mellitus.
    Burke TA; Sturkenboom MC; Ohman-Strickland PA; Wentworth CE; Rhoads GG
    Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):979-87. PubMed ID: 17605137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk for incident atrial fibrillation in patients who receive antihypertensive drugs: a nested case-control study.
    Schaer BA; Schneider C; Jick SS; Conen D; Osswald S; Meier CR
    Ann Intern Med; 2010 Jan; 152(2):78-84. PubMed ID: 20083826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Warfarin treatment and risk of myocardial infarction - A cohort study of patients with atrial fibrillation treated in primary health care.
    Wändell P; Carlsson AC; Holzmann MJ; Ärnlöv J; Johansson SE; Sundquist J; Sundquist K
    Int J Cardiol; 2016 Oct; 221():789-93. PubMed ID: 27428322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Warfarin Anticoagulation and Incident Dementia in a Community-Based Cohort of Atrial Fibrillation.
    Madhavan M; Hu TY; Gersh BJ; Roger VL; Killian J; Weston SA; Graff-Radford J; Asirvatham SJ; Chamberlain AM
    Mayo Clin Proc; 2018 Feb; 93(2):145-154. PubMed ID: 29329798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of statins and antihypertensive medications in relation to risk of long-standing persistent atrial fibrillation.
    Thacker EL; Jensen PN; Psaty BM; McKnight B; Longstreth WT; Dublin S; Newton KM; Smith NL; Siscovick DS; Heckbert SR
    Ann Pharmacother; 2015 Apr; 49(4):378-86. PubMed ID: 25628466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levothyroxine treatment and incident dementia in adults with atrial fibrillation.
    Wändell P; Carlsson AC; Li X; Sundquist J; Sundquist K
    Aging Clin Exp Res; 2020 Mar; 32(3):433-439. PubMed ID: 31119696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship between antihypertensive drug use and development of atrial fibrillation in hypertensive patients in a Primary Care center].
    Mena-Villalba AÁ; Lendínez-de la Cruz JM; Cubero-Gómez CM; Monsalvo-Moro M; Gutiérrez-Ruíz RC; García-Alfonsín A
    Semergen; 2014; 40(5):247-53. PubMed ID: 24485970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic therapy and the risk of new-onset dementia in elderly patients with atrial fibrillation.
    Wong CK; Huang D; Zhou M; Hai J; Yue WS; Li WH; Yin LX; Zuo ML; Feng YQ; Tan N; Chen JY; Kwan J; Siu CW
    Postgrad Med J; 2022 Feb; 98(1156):98-103. PubMed ID: 33184131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive control and new-onset atrial fibrillation: Results from the Swedish Primary Care Cardiovascular Database (SPCCD).
    Mourtzinis G; Schiöler L; Kahan T; Bengtsson Boström K; Hjerpe P; Hasselström J; Manhem K
    Eur J Prev Cardiol; 2017 Jul; 24(11):1206-1211. PubMed ID: 28470087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.